1,555
Participants
Start Date
June 13, 2022
Primary Completion Date
January 31, 2025
Study Completion Date
January 31, 2025
Prescreener database
Identify and characterize participants with reported memory complaints and/or cognitive impairment to determine the probability of randomization into a therapeutic AD clinical trial.
Re:Cognition Health, Fairfax
iResearch, Decatur
Charter Research, Lady Lake
ClinCloud, LLC, Maitland
K2 Medical Research, Maitland
Conquest Research, Winter Park
Charter Research, Winter Park
ClinCloud, LLC, Viera
Merritt Island Medical Research, Merritt Island
Visionary Investigator's Network, Aventura
Premiere Research Institute at Palm Beach Neurology, West Palm Beach
JEM Research Institute, Lake Worth
Renstar Medical Research, Ocala
Quest Research Institute, Farmington Hills
IPS Research, Oklahoma City
Clinical Trials of Texas, San Antonio
Pacific Research Network, San Diego
Syrentis Clinical Research, Santa Ana
OCT Research, Kelowna
Global Alzheimer's Platform Foundation
OTHER